Business Description
Zimmer Biomet Holdings Inc
NAICS : 339113
SIC : 3842
Compare
Compare
Traded in other countries / regions
ZBH.AustriaZ1BH34.BrazilZIM.GermanyZBH.MexicoZBH.Switzerland0QQD.UKZBH.USA IPO Date
2001-08-07Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 3.93 | |||||
| Interest Coverage | 7.23 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.94 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.1 | |||||
| 3-Year EBITDA Growth Rate | -11.8 | |||||
| 3-Year EPS without NRI Growth Rate | -36.8 | |||||
| 3-Year FCF Growth Rate | -3 | |||||
| 3-Year Book Growth Rate | -1.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 5.59 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.71 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.91 | |||||
| 9-Day RSI | 57.81 | |||||
| 14-Day RSI | 55.18 | |||||
| 6-1 Month Momentum % | 15.64 | |||||
| 12-1 Month Momentum % | -4.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | |||||
| Quick Ratio | 0.97 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 386.01 | |||||
| Days Sales Outstanding | 67.91 | |||||
| Days Payable | 58.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.76 | |||||
| Dividend Payout Ratio | 0.7 | |||||
| Forward Dividend Yield % | 0.76 | |||||
| 5-Year Yield-on-Cost % | 0.76 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.9 | |||||
| Operating Margin % | 17.18 | |||||
| Net Margin % | 3.33 | |||||
| ROE % | 1.89 | |||||
| ROA % | 1.06 | |||||
| ROIC % | 4.16 | |||||
| ROC (Joel Greenblatt) % | 13.37 | |||||
| ROCE % | 2.97 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 115.22 | |||||
| Forward PE Ratio | 17.99 | |||||
| PE Ratio without NRI | 91.84 | |||||
| Shiller PE Ratio | 40.77 | |||||
| Price-to-Owner-Earnings | 40.17 | |||||
| PS Ratio | 3.84 | |||||
| PB Ratio | 2.2 | |||||
| Price-to-Free-Cash-Flow | 24.3 | |||||
| Price-to-Operating-Cash-Flow | 20.75 | |||||
| EV-to-EBIT | 56.51 | |||||
| EV-to-Forward-EBIT | 28.62 | |||||
| EV-to-EBITDA | 21.49 | |||||
| EV-to-Forward-EBITDA | 15.63 | |||||
| EV-to-Revenue | 4.63 | |||||
| EV-to-Forward-Revenue | 4.49 | |||||
| EV-to-FCF | 29.28 | |||||
| Price-to-Projected-FCF | 1.2 | |||||
| Price-to-Median-PS-Value | 1.13 | |||||
| Earnings Yield (Greenblatt) % | 1.77 | |||||
| Forward Rate of Return (Yacktman) % | 5.19 |
How Zimmer Biomet Holdings Inc (ZBH) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ZBH
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Zimmer Biomet Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,939.9 | ||
| EPS (TTM) ($) | 1.1 | ||
| Beta | 0.97 | ||
| Volatility % | 20.75 | ||
| 14-Day RSI | 55.18 | ||
| 14-Day ATR ($) | 2.209448 | ||
| 20-Day SMA ($) | 125.002 | ||
| 12-1 Month Momentum % | -4.41 | ||
| 52-Week Range ($) | 100.39 - 135.05 | ||
| Shares Outstanding (Mil) | 210.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zimmer Biomet Holdings Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zimmer Biomet Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zimmer Biomet Holdings Inc Frequently Asked Questions
What is Zimmer Biomet Holdings Inc(ZBH)'s stock price today?
The current price of ZBH is $126.74. The 52 week high of ZBH is $135.05 and 52 week low is $100.39.
When is next earnings date of Zimmer Biomet Holdings Inc(ZBH)?
The next earnings date of Zimmer Biomet Holdings Inc(ZBH) is 2023-05-03 Est..
Does Zimmer Biomet Holdings Inc(ZBH) pay dividends? If so, how much?
The Dividend Yield %  of Zimmer Biomet Holdings Inc(ZBH) is 0.76% (As of Today), Highest Dividend Payout Ratio of Zimmer Biomet Holdings Inc(ZBH) was 1.14. The lowest was 0.11. And the median was 0.33. The  Forward Dividend Yield % of Zimmer Biomet Holdings Inc(ZBH) is 0.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
